Journals / Türk Kardiyoloji Derneği Arşivi / 2009 / Cilt: 37 - Sayı: 5

Mid-term results of surgical radiofrequency ablation for permanent atrial fibrillation

Kalıcı atriyal fibrilasyonun cerrahi radyofrekans ablasyon ile tedavisi: Orta dönem sonuçlarımız

Pages
321–327
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Radiofrequency ablation is increasingly performed for the treatment of AF, yielding more successfulresults.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Atrial fibrillation (AF) is a common problem incardiac surgery patients.
📊
Key Findings & Data:Study design: The study included 79 patients (53 females,26 males; mean age 53±11 years; range 32 to 76 years)who underwent concomitant RFA for AF during open heartsurgery under cardiopulmonary bypass.
💡
Conclusion & Impact:Conclusion: Radiofrequency ablation is increasingly performed for the treatment of AF, yielding more successfulresults.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: Atrial fibrillation (AF) is a common problem incardiac surgery patients. We evaluated the mid-term resultsof patients who underwent open heart surgery and radiofrequency ablation (RFA). Study design: The study included 79 patients (53 females,26 males; mean age 53±11 years; range 32 to 76 years)who underwent concomitant RFA for AF during open heartsurgery under cardiopulmonary bypass. The majority ofpatients were in NYHA class III (n=68, 86.1%) and had (n=67,84.8%) rheumatic heart disease. The mean preoperative AFduration was 47±41 months. The most frequent procedureinvolved the mitral valve (64 replacements, 11 reconstructions). A unipolar probe was used in 60 patients (76%) anda bipolar probe in 19 patients (24.1%). The mean follow-upperiod was 20.8±14.7 months (range 1 to 59 months). Results: The mean perfusion and cross-clamp times were102.4±15.7 min (range 48 to 171 min) and 76.1±25.0 min(range 27 to 145 min), respectively. In-hospital mortalityoccurred in two patients (2.5%) and late mortality occurredin three patients (3.8%). One patient (1.3%) required implantation of a permanent pacemaker. During discharge, 58patients (73.4%) were in sinus rhythm, of which nine (15.3%)developed recurrent AF within a mean of 5.3±4.4 months(range 2 to 12 months). Transient atrial flutter was seen inthree patients (3.8%). Logistic regression analysis showedno risk factor to significantly affect early or late AF recurrence. Six- and 12-month rates of AF-free rhythm were94.3±3.9% and 87.6±5.9% for operations performed bythe year 2006 and 95.2±3.3% and 92.2±4.4% afterwards,respectively (p=0.0001). There was no significant differencewith respect to survival between patients discharged withAF and in sinus rhythm (p>0.05). Conclusion: Radiofrequency ablation is increasingly performed for the treatment of AF, yielding more successfulresults.

Özet

Amaç: Atriyal fibrilasyon (AF) açık kalp cerrahisi uygulananhastalarda sık karşılaşılan bir sorundur. Bu çalışmada açıkkalp ameliyatına alınarak radyofrekans ablasyon (RFA) uygulanan hastaların orta dönem sonuçları incelendi. Ça lış ma pla nı: Çalışmaya açık kalp cerrahisiyle birliktekalıcı AF nedeniyle eşzamanlı olarak RFA uygulanan 79hasta (53 kadın, 26 erkek; ort. yaş 53±11; dağılım 32-76)alındı. Hastaların büyük çoğunluğu (68 hasta, %86.1)NYHA sınıf III idi; 67 hastada (%84.8) romatizmal kalphastalığı vardı. Ameliyat öncesi ortalama AF süresi 47±41ay idi. Tüm hastalar kardiyopulmoner bypass kullanılarakameliyat edildi. En sık uygulanan işlem mitral kapak işlemleriydi (64 replasman 11 rekonstrüksiyon). Altmış hastada(%76) unipolar, 19 hastada (%24.1) bipolar prob kullanıldı.Ortalama takip süresi 20.8±14.7 ay (dağılım 1-59 ay) idi. Bul gu lar: Ortalama perfüzyon ve kros-klemp süreleri sırasıyla 102.4±15.7 dk (dağılım 48-171 dk) ve 76.1±25.0 dk(dağılım 27-145 dk) bulundu. Hastane mortalitesi iki hastada(%2.5), geç dönem mortalite üç hastada (%3.8) görüldü.Ameliyat sonrası dönemde bir hastaya kalıcı yürek pili (%1.3)yerleştirildi. Taburculuk sırasında 58 hasta (%73.4) sinüsritminde idi. Bu hastaların dokuzunda (%15.3) yeniden AFgelişti. Ortalama AF gelişme süresi 5.3±4.4 ay (dağılım 2-12ay) idi. Üç hastada (%3.8) kısa süreli atriyal flutter görüldü.Lojistik regresyon analizinde erken ve geç dönemde AF gelişim riskini artıracak bir faktör saptanmadı. 2006 yılı öncesive sonrası yapılan ameliyatlarda 6. ve 12. aylarda sinüsritminde seyir oranları ilk dönem için sırasıyla %94.3±3.9ve %87.6±5.9, ikinci dönem için %95.2±3.3 ile %92.2±4.4bulundu (p=0.0001). Atriyal fibrilasyon ve sinüs ritmi iletaburcu edilen hasta grupları arasında ortalama sağkalımaçısından anlamlı fark bulunmadı (p>0.05). So nuç: Atriyal fibrilasyonun RFA ile tedavisi giderek artansıklıkta kullanılmakta ve başarı oranları da gün geçtikçeartmaktadır.

🔖

Cite This Article

MATARACI, İ., POLAT, A., KIRALİ, K., MERT, B., AKSÜT, M. (2022). Mid-term results of surgical radiofrequency ablation for permanent atrial fibrillation. Türk Kardiyoloji Derneği Arşivi, Cilt: 37 - Sayı: 5, 321–327. https://ajindex.com/articles/633371

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Uyarel H, Onat A, Yüksel H, Can G, Ordu S, Dursunoğlu D. Incidence, prevalence, and mortality estimates for chronic atrial fibrillation in Turkish adults. [Article in Turkish] Türk Kardiyol Dern Arş 2008;36:214-22
  2. Bahar I, Akgül A, Babaroğlu S, Ozatik MA, Turhan H, Göl MK ve ark. Kronik atriyal fibrilasyonda mekanik mitral kapak replasmanı ile birlikte radyofrekans atriyal ablasyonun etkinliği. Anadolu Kardiyol Derg 2006; 6:41-8
  3. Geidel S, Lass M, Boczor S, Kuck KH, Ostermeyer J. Surgical treatment of permanent atrial fibrillation during heart valve surgery. Interact Cardiovasc Thorac Surg 2003;2:160-5
  4. Chen SA, Tai CT. Catheter ablation of paroxysmal atrial fibrillation. Cardiol Rev 2005;13:87-94
  5. Ad N. The maze procedure: past, present and future. In: Sie HT, D’Ancona G, Bartolozzi F, Beukema W, Doty DB, editors. Manual of surgical treatment of atrial fibrillation. Massachusetts: Blackwell Publishing; 2008. p. 102-12
  6. Haïssaguerre M, Shah DC, Jaïs P, Hocini M, Yamane T, Deisenhofer I, et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000;102:2463-5
  7. Haïssaguerre M, Hocini M, Sanders P, Takahashi Y, Rotter M, Sacher F, et al. Localized sources maintaining atrial fibrillation organized by prior ablation. Circulation 2006;113:616-25
  8. Nanthakumar K, Lau YR, Plumb VJ, Epstein AE, Kay GN. Electrophysiological findings in adolescents with atrial fibrillation who have structurally normal hearts. Circulation 2004;110:117-23
  9. Todd DM, Skanes AC, Guiraudon G, Guiraudon C, Krahn AD, Yee R, et al. Role of the posterior left atrium and pulmonary veins in human lone atrial fibrillation: electrophysiological and pathological data from patients undergoing atrial fibrillation surgery. Circulation 2003;108:3108-14
  10. Guang Y, Zhen-jie C, Yong LW, Tong L, Ying L. Evaluat ion of clinical treatment of atrial fibrillation associated with rheumatic mitral valve disease by radiofrequency ablation. Eur J Cardiothorac Surg 2002;21:249-54
  11. Deneke T, Khargi K, Müller KM, Lemke B, Mügge A, Laczkovics A, et al. Histopathology of intraoperatively induced linear radiofrequency ablation lesions in patients with chronic atrial fibrillation. Eur Heart J 2005;26:1797-803
  12. Laurent G, De Chillou C, Bertaux G, Poull IM, Martel A, Andronache M, et al. Simple and efficient identification of conduction gaps in post-ablation recurring atrial flutters. Europace 2006;8:7-15
  13. Chen MC, Chang JP, Chang HW. Preop